CME Group GC Marchese reports 3,055 shares
CME’s Sr MD and General Counsel John Clifford Marchese reported initial direct ownership of 3,055 Class A common shares on a Form 3.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CME GROUP INC. (CME) reported that John Clifford Marchese, who serves as Sr MD, General Counsel, filed an initial statement of beneficial ownership of securities. The filing lists 3,055 shares of Common Stock Class A held with direct ownership, with no specific purchase or sale transaction reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Common Stock Class A | -- | -- | -- |
Key Figures
Key Terms
Form 3 regulatory
beneficial ownership financial
Common Stock Class A financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Is the CME (CME) Form 3 for John Clifford Marchese a report of a trade?
What class of CME (CME) stock does John Clifford Marchese hold?
What is John Clifford Marchese’s role at CME (CME) in this Form 3?
AI-generated analysis. How Rhea-AI works. Not financial advice.